ARCHIVES

Duke Halts Third Trial; Coauthor Disputes Claim That Data Validation Was Blinded

This article is from The Cancer Letter archive.

Vol. 35 No. 39 | October 23, 2009

Download PDF Visit The Full Archive

Related Articles

In Brief: Bioassay Prime Contract Renewed For Four Years, $34.2 Million; Canellos Quits As Clinical Director

June 20, 1975

Bisphosphonates May Reduce Recurrent Breast Cancer

December 25, 2009

Chabner Says Some Group Satellites Causing Concern Because Of Lack Communications

March 4, 1983

Trials Approved by NCI CTEP For the Month of January

January 27, 2012

CCIRC Considers Programs Involved with Including Multimodality Studies

October 10, 1975

Society Growth continues, With OS The Largest; ASCO Plans to Reduce flow Of Medical Oncologists; AACR To Impose Page Charges for “Cancer Research:

May 31, 1985